← Leaderboards
X. Shawn Liu
Whitehead Institute For Biomedical Res
$4,173,782
Attributed
$5,401,926
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,401,926 · 4
By mechanism
R01$4,406,263 · 2
R00$734,735 · 1
K99$260,928 · 1
Top collaborators
- Antonio Bedalov3 shared
Most similar at Whitehead Institute For Biomedical Res
Same institution · by research overlap
- Katherine Jean Wert$1,371,752
Others in their field
Other Emerging Leaders on “Mutation”
- Leonard Freedman · Leidos Biomedical Research, Inc.$85,874,322
- John Damon Chodera · Sloan-Kettering Inst Can Research$48,421,310
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$38,744,543
- Lynn Briscoe · Leidos Biomedical Research, Inc.$38,032,945
- Maria C Carrillo · Indiana University Indianapolis$19,445,642
- James Dale Berry · Brigham And Women'S Hospital$19,118,191
Research focus
MutationTranscriptome SequencingCellsPromoterPhenotypeDna MethylationNeuronsProteinsPublic HealthGenetic TranscriptionEpigenetic ProcessDemethylationElectrophysiology (Science)Experimental StudyMutantAffectGenomeInduced Pluripotent Stem CellDefectPlayDnmt3aDisease PhenotypeEffective TherapyMethylome
Grant awards (14)
MeCP2 reactivation from the inactive X chromosome as treatment for Rett syndrome$797,991
R01 · FY2025 · MH · contact PI
Epigenetic Mechanisms Contributing to the Pathogenesis of ALS/FTD with GGGGCC Repeat Expansion Mutation at the C9orf72 Locus$405,751
R01 · FY2025 · NS · contact PI
Epigenetic Mechanisms Contributing to the Pathogenesis of ALS/FTD with GGGGCC Repeat Expansion Mutation at the C9orf72 Locus$163,013
R01 · FY2025 · NS · contact PI
MeCP2 reactivation from the inactive X chromosome as treatment for Rett syndrome$809,324
R01 · FY2024 · MH · contact PI
Epigenetic Mechanisms Contributing to the Pathogenesis of ALS/FTD with GGGGCC Repeat Expansion Mutation at the C9orf72 Locus$405,912
R01 · FY2024 · NS · contact PI
Epigenetic mechanisms contributing to the pathogenesis of ALS/FTD with GGGGCC repeat expansion mutation at the C9orf72 locus$163,013
R01 · FY2024 · NS · contact PI
MeCP2 reactivation from the inactive X chromosome as treatment for Rett syndrome$848,974
R01 · FY2023 · MH · contact PI
Epigenetic Mechanisms Contributing to the Pathogenesis of ALS/FTD with GGGGCC Repeat Expansion Mutation at the C9orf72 Locus$406,067
R01 · FY2023 · NS · contact PI
Epigenetic mechanisms contributing to the pathogenesis of ALS/FTD with GGGGCC repeat expansion mutation at the C9orf72 locus$406,218
R01 · FY2022 · NS · contact PI
Role of the Rett Syndrome-causing gene MeCP2 in 3D chromosomal organization and rescue of cellular disease phenotypes$249,000
R00 · FY2022 · MH · contact PI
Role of the Rett Syndrome-causing gene MeCP2 in 3D chromosomal organization and rescue of cellular disease phenotypes$242,612
R00 · FY2021 · MH · contact PI
Role of the Rett Syndrome-causing gene MeCP2 in 3D chromosomal organization and rescue of cellular disease phenotypes$243,123
R00 · FY2020 · MH · contact PI
Role of the Rett Syndrome-causing gene MeCP2 in 3D chromosomal organization and rescue of cellular disease phenotypes$130,464
K99 · FY2019 · MH · contact PI
Role of the Rett Syndrome-causing gene MeCP2 in 3D chromosomal organization and rescue of cellular disease phenotypes$130,464
K99 · FY2018 · MH · contact PI